Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Malignant Glioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00301873
What this trial is testing

Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma

Who this might be right for
Brain TumorsOsteoporosisCentral Nervous System(CNS)Malignancies
Duke University 60
Early research (Phase 1)Study completedNCT02197169
What this trial is testing

DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors

Who this might be right for
Glioblastoma or Gliosarcoma
DNAtrix, Inc. 37
Early research (Phase 1)Study completedNCT00509431
What this trial is testing

Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 19
Testing effectiveness (Phase 2)Study completedNCT02540161
What this trial is testing

Phase 2 Study of Sym004 for Adult Patients With Recurrent Glioblastoma

Who this might be right for
Malignant Glioma
Annick Desjardins 43
Testing effectiveness (Phase 2)Study completedNCT04740190
What this trial is testing

Talazoparib - Carboplatin for Recurrent High-grade Glioma With DDRd

Who this might be right for
Recurrent GliomaRecurrent GlioblastomaPoly ADP Ribose Polymerase (PARP) Inhibitor+2 more
The University of Hong Kong 33
Testing effectiveness (Phase 2)Study completedNCT00679354
What this trial is testing

Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy

Who this might be right for
Childhood High-grade Cerebellar AstrocytomaChildhood High-grade Cerebral AstrocytomaRecurrent Childhood Anaplastic Astrocytoma+7 more
National Cancer Institute (NCI) 30
Very early researchStudy completedNCT04937413
What this trial is testing

The PCSK9i Inhibitor Evolocumab - a Surgical Trial of Pharamcodynamics and Kinetics Evaluation

Who this might be right for
Malignant GliomaGlioblastoma
Duke University 32
Testing effectiveness (Phase 2)Study completedNCT00704288
What this trial is testing

Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Exelixis 222
Early research (Phase 1)Study completedNCT00003597
What this trial is testing

Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors

Who this might be right for
Cancer
Children's Oncology Group 16
Testing effectiveness (Phase 2)Looking for participantsNCT01906385
What this trial is testing

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

Who this might be right for
Glioma
Cerenome 55
Early research (Phase 1)Ended earlyNCT00003926
What this trial is testing

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorChordoma+6 more
Masonic Cancer Center, University of Minnesota 13
Early research (Phase 1)Not Yet RecruitingNCT06737146
What this trial is testing

Study of MT027 in Patients with Recurrent or Progressive High-grade Glioma

Who this might be right for
High-grade Glioma
Suzhou Maximum Bio-tech Co., Ltd. 12
Testing effectiveness (Phase 2)Ended earlyNCT02885324
What this trial is testing

Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaMalignant Brain Tumor+1 more
Indiana University 4
Early research (Phase 1)Study completedNCT04295759
What this trial is testing

INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaAnaplastic Oligodendroglioma+3 more
Pediatric Brain Tumor Consortium 13
Early research (Phase 1)Looking for participantsNCT04573140
What this trial is testing

RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)

Who this might be right for
Adult GlioblastomaHigh Grade GliomaWHO Grade III or IV Malignant Glioma
University of Florida 28
Testing effectiveness (Phase 2)Study completedNCT00104091
What this trial is testing

Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors

Who this might be right for
Glioblastoma Multiforme
Teva Branded Pharmaceutical Products R&D, Inc. 56
Testing effectiveness (Phase 2)Study completedNCT00717197
What this trial is testing

Study of Capecitabine to Treat Recurrent High Grade Gliomas

Who this might be right for
Malignant Glioma
University of Florida 30
Early research (Phase 1)Study completedNCT03043391
What this trial is testing

Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children

Who this might be right for
Malignant GliomaAnaplastic AstrocytomaAnaplastic Oligoastrocytoma+8 more
Istari Oncology, Inc. 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more
National Cancer Institute (NCI) 6,452
Testing effectiveness (Phase 2)Study completedNCT00010049
What this trial is testing

Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 105
Next Page